Abstract. Impaired insulin secretion and insulin resistance are thought to be two major causes of type 2 diabetes mellitus. There are two kinds of diabetic model mice: one is a K ATP channel knockout (Kir6.2KO) mouse which is defective in glucose-induced insulin secretion, and the other is a transgenic mouse expressing the tyrosine kinase-deficient (dominantnegative form of) human insulin receptor (hIR KM TG), and which has insulin resistance in muscle and fat. However, all of these mice have no evidence of overt diabetes. To determine if the double mutant Kir6.2KO/hIR KM TG mice would have diabetes, we generated mutant mice by crossbreeding, which would show both impaired glucose-induced insulin secretion and insulin resistance in muscle and fat. We report here that: 1) blood glucose levels of randomly fed and 6 h fasted double mutant (Kir6.2KO/hIR KM TG) mice were comparable with those of wild type mice; 2) in intraperitoneal glucose tolerance test (ipGTT), Kir6.2KO/hIR KM TG mice had an impaired glucose tolerance; and 3) during ipGTT, insulin secretion was not induced in either Kir6.2KO/hIR KM TG or Kir6.2KO mice, while the hIR KM TG mice showed a more prolonged insulin secretion than did wild type mice; 4) hyperinsulinemic euglycemic clamp test revealed that Kir6.2KO, Kir6.2KO/hIR KM TG and hIR KM TG mice, showed decreased whole-body glucose disposal compared with wild type mice; 5) Kir6.2KO, but not Kir6.2KO/hIR KM TG mice had some obesity and hyperleptinemia compared with wild type mice. Thus, the defects in glucose-induced insulin secretion (Kir6.2KO) and an insulin resistance in muscle and fat (hIR KM TG) were not sufficient to lead to overt diabetes.
INSULIN secretion from pancreatic b cells is stimulated by the initiator (i.e., glucose) at and above basal levels [1] , and enhanced by several physiological potentiators including incretins such as glucagon-like peptide 1 (GLP-1) [2] and glucose-dependent insulinotropic polypeptide (GIP) [3] released from enteroendocrine cells in response to nutrients as well as acetylcholine and pituitary adenylate cyclase-activating polypeptide (PACAP) to vagal nerve reflex by meal ingestion [4] [5] [6] . Glucose-induced insulin secretion is regulated by the K ATP channel-dependent pathway [1] . Incretin-induced insulin secretion is mediated by intracellular cyclic AMP, increased intracellular calcium and partially linked to the K ATP channel pathway [1] . The K ATP channel of the pancreatic b cell comprises two subunits: a receptor of sulfonylureas (SUR1), and an inward rectifier K + channel member, Kir6.2 [1] . Miki et al. have generated K ATP channel-deficient mice by genetic disruption of Kir6.2 (Kir6.2KO) [7] , and studies of Kir6.2KO mice have demonstrated that: 1) there was no significant insulin secretion in response to glucose in Kir6.2KO mice; 2) Kir6.2KO mice had only a mild impairment in glucose tolerance but not overt diabetes; 3) Kir6.2KO mice had a severe defect in glucagon secretion in response to systemic hypoglycemia due to lack of glucose sensing by glucoseresponsive (GR) neurons in ventro-medial hypothalamus (VMH) caused by absence of the K ATP channel [8] ; 4) insulin-stimulated glucose uptake in skeletal muscles and adipose tissues of Kir6.2KO mice were enhanced in vivo, compared with findings in wild-type mice [9] .
We also have generated a transgenic mouse expressing the tyrosine kinase-deficient (dominant-negative form of) human insulin receptor (hIR KM TG) [10] . The mutated human insulin receptor, in which lysine residue 1030 in the putative ATP-binding site of the tyrosine kinase domain substituted Met for Lys (hIR KM ), had no kinase activity, no insulin-related effects and acted as a dominant negative form [11] . Heterozygous transgenic mice (hIR KM TG) did not exhibit diabetes, as assessed by intraperitoneal glucose tolerance test (ipGTT), despite the high expression of a dominant negative human insulin receptor in various tissues, including major insulin-target tissues, muscle and adipose tissues in which insulin effects were strongly inhibited [10, 12] .
The liver is another major insulin target. Expression of the exogenous mutant transgene in the liver of hIR KM TG mice was about one tenth that of the endogenous normal mouse insulin receptor [10] and repression of insulin signaling by a small amount of exogenous dominant negative mutant insulin receptor (IR) in the liver was insufficient. Therefore, the insulin action in the liver of hIR KM TG mice was not inhibited [12] . We proposed that impaired insulin action in the liver might be needed for overt diabetes to develop [10, 12] . Homozygous transgenic mice had hyperinsulinemia but not diabetes [13] . Since homozygous mice were obtained at an unexpected low frequency (data not shown), we used heterozygous transgenic mice (hIR KM TG) as models of insulin resistance in the following experiments. The hIR KM TG mice clearly showed insulin resistance by ipGTT (Fig. 4) , Insulin tolerance test (ITT) (Fig. 6 ) and in the hyperinsulinemic euglycemic clamp test (Fig. 7) .
The Kir6.2KO mice were spared development of hyperglycemia and diabetes, because these mice retained incretin-induced insulin secretion in response to mixed-meal ingestion while on a normal diet [7] . However, if Kir6.2KO mice acquired the two factors of aging (55~60 weeks old) and insulin resistance due to obesity, the diabetes of the mice became evident [1] .
We crossbred Kir6.2KO with hIR KM TG mice to determine if the double mutant (Kir6.2KO/hIR KM TG) mice would have diabetes. Unexpectedly, the compound effect of impaired glucose-induced insulin secretion of b-cell (Kir6.2KO) and peripheral insulin resistance in muscle and fat (hIR KM TG) failed to lead to diabetes. Our findings suggest that diabetes does not develop in mice in the absence of a liver defect in insulin action, as reported previously [10, 12] .
Materials and Methods

Materials
An anti-insulin receptor b antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Human specific anti-insulin receptor antibody (5D9) was kindly provided by Dr. Richard A. Roth (Stanford University, Palo Alto, CA, USA). Human regular insulin was purchased from Novo Nordisk (Bagsvared, Denmark). Unless stated otherwise, materials of reagent grade were purchased from Nacalai Tesque (Kyoto, Japan), Wako Pure Chemical (Osaka, Japan) or Sigma (St. Louis, MO, USA).
Mice
The Kir6.2KO mice were kindly provided by Dr. S. Seino (Chiba University, Chiba, Japan) [4] . C57BL/6, hIR KM TG, Kir6.2KO and Kir6.2KO/hIR KM TG mice were maintained at the Institute for Experimental Animals, University of Tokushima, and experiments were carried out in accordance with international care regulations. We used C57BL/6 mice as control mice (WT: wild type), because we bred F0 of hIR KM TG with C57BL/6 and bred Kir6.2KO with C57BL/6. Mice were kept under a 12 h light/dark cycle with the light cycle between 0900 h and 2100 h and were allowed free access to tap water and standard chow. In the experiments for fasting, mice were moved into new cages without standard chow to eliminate half-eaten chow dropped into the sawdust.
Generation of hIR KM TG mice and detection of hIR KM gene expression Fertilized C57BL/6 eggs were microinjected with the DNA fragment, carrying the cDNA encoding a tyrosine kinase-deficient human insulin receptor under control of the native promoter (hIR KM TG mice) [10] , as described elsewhere [14] . C57BL/6 mice were obtained from specific pathogen-free (SPF) stocks of Nippon Clea (Osaka, Japan). The offspring of hIR KM TG mice were identified by means of (digoxigenin)-11dUTP-labeled (DIG) Southern blot hybridization (Roche, Mannheim, Germany), as described elsewhere [13] .
Generation of Kir6.2-deficient mice and detection of Kir6.2-/-gene expression
The homologous recombinant clone was identified by Southern blot analysis, and homozygous mice (Kir6.2KO) were generated, as described elsewhere [7] .
Generation of Kir6.2KO/hIR KM TG mice and detection of Kir6.2KO/hIR KM TG gene expression Kir6.2KO/hIR KM TG mice were generated by crossbreeding hIR KM TG mice with Kir6.2KO mice and the genotype was confirmed by Southern blot analysis, as described elsewhere [7, 13] .
Western blot analysis
Mice were anesthetized by giving an intraperitoneal injection of pentobarbital (64.8 mg/kg body weight), and the soleus muscles were isolated. Membrane fractions were prepared as follows: Muscles were homogenized in homogenizing buffer (20 mmol/l Tris-HCl (pH 7.5), 1 mmol/l EDTA, 20 mmol/l NaF, 1 mmol/l Na 3 VO 4 , 1 mmol/l dithiothreitol, 1 mmol/l phenylmethyl sulfonyl fluoride (PMSF), 4 mg/ml aprotinin, 4 mg/ml pepstatin, 4 mg/ml leupeptin), using a Polytron PT-10 homogenizer (Brinkman Instruments, Westbury, NY). The samples were then centrifuged at 600 × g for 10 min at 4°C. The resulting supernatant was then centrifuged at 105,000 × g for 60 min at 4°C. The precipitates were suspended in lysis buffer (20 mmol/l Tris-HCl (pH 7.4), 1% Nonidet P-40, 100 mmol/l NaCl, 10 mmol/l EDTA, 1 mmol/l Na 3 VO 4 , 1 mmol/l NaF, 1 mmol/l dithiothreitol, 1 mmol/l PMSF, 4 mg/ml aprotinin, 4 mg/ml pepstatin, 4 mg/ml leupeptin). The samples were centrifuged at 18,500 × g for 10 min at 4°C. The protein content of the supernatants was determined by Bradford's method using Bio-Rad Protein Assay kit (Hercules, CA, USA). These detergent-extracted supernatants were separated by 7% SDS-PAGE under reducing conditions and transferred to BA85 nitrocellulose membranes (Schleicher & Schuell, Keene, NH, USA). The membranes were blocked for 60 min with blocking buffer containing 5%w/v skim milk, 250 mmol/l Tris-HCl (pH 7.5), 136 mmol/l NaCl, 2.5 mmol/l KCl, at room temperature. The blocked membranes were blotted with an anti-insulin receptor b antibody (Santa Cruz Biotech.) and the signals were detected by enhanced chemiluminescence.
Measurement of glucose concentration
The four genotypes (WT, hIR KM TG, Kir6.2KO, Kir6.2KO/hIR KM TG) of male mice (12-16 weeks old) were analyzed. After these mice had been fasted for 6 h (from 0800 h to 1400 h), blood samples were obtained at 1400 h from the tail vein. Blood samples were obtained at 1400 h from the tail vein of randomfed mice. Blood glucose concentration was measured with whole blood by an enzyme electrode method with use of Glucocard (Arkray, Kyoto, Japan).
Mixed meal tolerance test
The four genotypes (WT, hIR KM TG, Kir6.2KO, Kir6.2KO/hIR KM TG) of male mice (12-18 weeks old) were fasted for 12 h (0900 h-2100 h), and then allowed free access to standard chow for one hour (2100 h-2200 h). They were then moved into new cages with no chow at 2200 h. Blood samples were obtained from the tail vein, and blood glucose concentrations were measured at 2100 h, 2200 h, 2300 h, and 2400 h.
Intraperitoneal glucose tolerance tests
Intraperitoneal glucose tolerance tests (ipGTT) were performed on male mice of the four genotypes (12-18 weeks old). Glucose (2 g/kg body weight) was given intraperitoneally after a 14 h fasting (1800 h-0800 h). Blood samples were taken from the tail vein at 0, 10, 20, 30, 60 and 120 min after an injection of glucose. Glucose levels were measured as described above.
Plasma insulin concentrations were determined on the four genotypes (12-15 weeks old) after a 14 h (1800 h-0800 h) fast. Blood samples were obtained from the tail vein at 0, 10, 20, 30 and 60 min after an intraperitoneal glucose injection (2 g/kg body weight). Plasma insulin levels were measured by a commercial insulin ELISA kit (Morinaga, Yokohama, Japan) using mouse insulin as a standard.
Intraperitoneal insulin tolerance tests
Insulin tolerance tests were performed on male mice at 12-17 weeks of age after intraperitoneal injection of 0.2 units per kg body weight of human insulin (Novo Nordisk, Bagsvared, Denmark), after a 6 h (0830 h-1430 h) fast by removing the chow and changing the cage. Blood samples were taken from the tail vein at 0, 30, 60 and 120 min after an injection of insulin. Glucose levels were measured as described above.
Hyperinsulinemic euglycemic clamp studies
Insulin-mediated whole-body glucose uptake was determined in 15 week-old anesthetized male mice by a hyperinsulinemic euglycemic clamp test [15] . After a 14 h (1800 h-0800 h) fast, mice were anesthetized by giving an intraperitoneal injection of pentobarbital, and catheters were inserted into the right jugular vein. Insulin was infused continuously at 15 mU/kg body weight/min. Blood glucose was measured every 10 min by an enzyme electrode method. Injection of glucose solution (250 g/l) was initiated at time 0 when the blood glucose level was lower than 100 mg/dl; the rate of infusion was adjusted to maintain the whole blood glucose concentration at approximately 110 mg/dl. The total body glucose uptake represents the glucose infusion rate (GIR) during the last 20 min.
Lipid metabolism
Lipid metabolism was evaluated on three genotypes of male mice (12-17 weeks old). Blood samples were obtained from the tail vein after a 14 h (1800 h-0800 h) fast. Serum levels of triglyceride, total cholesterol and free fatty acid were determined using conventional enzymatic methods (Wako, Osaka, Japan). Plasma leptin levels were measured using ELISA mouse leptin kit (Morinaga, Yokohama, Japan) according to procedures provided by the manufacturer. We also measured the weight of epididymal fat.
AKT in vitro kinase assay
AKT kinase activity was measured using AKTide-2T [16] as a substrate, as described previously [17] . After male mice (12-17 weeks old) had been fasted for 12 h (0900 h-2100 h), mice were anesthetized by giving an intraperitoneal injection of pentobarbital (64.8 mg/kg body weight) and were given human regular insulin (0.75 U/kg) intraperitoneally at 2100 h. Livers were isolated at 15 min after the injection of insulin and homogenized in homogenizing buffer containing 20 mmol/l Tris-HCl (pH 7.5), 140 mmol/l NaCl, 1 mmol/l MgCl 2 , 1 mmol/l CaCl 2 , 0.5 mmol/l Na 3 VO 4 , 50 mmol/l b-glycerophosphate, 20 mmol/l Na 4 P 2 O 7 , 20 mmol/l NaF, 10% (v/v) glycerol, 1% (v/v) Nonidet P-40, 1 mmol/l dithiothreitol and 1 mM PMSF, using a Polytron PT-10 homogenizer (Brinkman Instruments, Westbury, NY, USA). After centrifugation at 15,000 × g for 10 min at 4°C, the total cell lysates (2 mg protein) were immunoprecipitated with an anti-AKT antibody [18] . Immunoprecipitated enzymes were incubated in 30 ml of reaction mixture containing 20 mmol/l HEPES-NaOH (pH 7.4), 100 mmol/l NaCl, 10 mmol/l NaF, 10 mmol/l b-glycerophosphate, 0.1 mmol/l Na 3 VO 4 , 10 mmol/l MgCl 2 , 0.5 mmol/l EGTA, 1 mmol/l protein kinase inhibitor, 1 mmol/l dithiothreitol, 5 mmol/l cold ATP, 1.1 × 10 8 Bq of [g-32 P] ATP and 50 mmol/l AKTide-2T for 10 min at 37°C. The reactions were terminated by adding 10 ml of 8N HCl and spotted onto P81 phosphocellulose paper (Whatman, Rockland, MA, USA) then washed 5 times with 0.5% phosphoric acid. Radioactivity was measured in a liquid scintillation counter.
Statistical analysis
Results are presented as mean ± SD. Each variable was analyzed using Student's t test. A p value of less than 0.05 was considered to have statistical significance.
Results
Generation of Kir6.2KO/hIR KM TG mice
The hIR KM TG mice express the tyrosine kinasedeficient (dominant negative) human insulin receptor under control of the native insulin receptor promoter [10] . Expressions of exogenous mutant human insulin receptors were detected by western blotting. Extracts from membrane fractions of the soleus muscle were immunoprecipitated using a human specific monoclonal antibody (5D9) against a subunit of the human insulin receptor and were analyzed by western blotting using anti-insulin receptor b antibody. As shown in Fig. 1A , bands corresponding to human mutant insulin receptor b-subunit (hIRb) were observed in samples from hIR KM TG and Kir6.2KO/hIR KM TG mice. Kir6.2KO/hIR KM TG mice were obtained by crossbreeding heterozygous hIR KM TG mice with homozygous Kir6.2KO mice. Homozygous Kir6.2 knockout (Kir6.2KO and Kir6.2KO/hIR KM TG) mice had a 4.5 kb band of the targeted allele as shown in Fig. 1B [7] . The 5.8 kb band is derived from Kir6.2 genomic DNA of WT mice, while heterozygous mice have both the 4.5 and 5.8 kb bands. Thus, we confirmed the genotypes of Kir6.2KO/hIR KM TG mice by western and southern analyses.
Kir6.2KO/hIR KM TG mice maintain normal glucose levels in both fasting and random-fed state One criterion for the onset of diabetes is the high level of fasting blood glucose. To evaluate the state of glucose homeostasis, after random-fed and 6 hr fast blood glucose levels were measured (Fig. 2) . Blood glucose levels in random-fed hIR KM TG mice were slightly higher, but not statistically different compared with findings in WT mice. In Kir6.2KO/hIR KM TG and Kir6.2KO mice, random-fed glucose levels were the same as in WT mice.
After a 6 h fast, Kir6.2KO mice had lower glucose levels compared with WT mice, as reported elsewhere (P<0.05) [9] . After a 12 or 14 h fast, blood glucose levels in Kir6.2KO/hIR KM TG mice as well as in Kir6.2KO mice were significantly lower than those in WT mice (Figs. 3, 4) . Fasting and random-fed blood glucose levels of Kir6.2KO/hIR KM TG were not statistically higher than levels in WT mice. Based on fasting blood glucose levels, Kir6.2KO/hIR KM TG mice, as well as hIR KM TG and Kir6.2KO mice, did not exhibit diabetes.
Mixed meal tolerance test of Kir6.2KO and Kir6.2KO/ hIR KM TG mice After a 12 h fast (0900 h-2100 h), blood glucose levels of Kir6.2KO/hIR KM TG and Kir6.2KO mice Membrane fractions prepared from soleus muscle were immunoprecipitated with a human specific anti-IR antibody (5D9) and the immunoprecipitates were subjected to western blot analysis using an anti-insulin receptor b antibody. The band corresponding to human insulin receptor b subunit is indicated by an arrow. WT: wild type (control); hIR KM TG: heterozygous transgenic mouse expressing dominant-negative form of human insulin receptor; Kir6.2KO: homozygous K ATP channel-deficient mouse by genetic disruption of Kir6.2; Kir6.2KO/ hIR KM TG: heterozygous expressing mutant human insulin receptor and homozygous Kir6.2 knockout mouse B) Southern blot analysis for detection of the targeted allele. Genomic DNA was digested with EcoR I and Bgl II, and then hybridized with the probe on nitrocellulose membranes, as described [13] . The 4.5 kb and 5.8 kb bands are derived from targeted allele and Kir6.2 genomic DNA, respectively [7] . Lanes: +/+, wild type; +/-, heterozygote; -/-, homozygote.
were significantly lower than that in WT mice (Fig. 3) . The same result is shown in Fig. 4 . These low levels may be due to the absence of glucagon secretion in response to systemic hypoglycemia in Kir6.2KO and Kir6.2KO/hIR KM TG mice [8] .
When allowing free access to standard chow for one hour (at 2200 h), blood glucose levels of Kir6.2KO/ hIR KM TG and Kir6.2KO mice were significantly higher than that in WT mice probably due to the lack of glucose-induced insulin secretion in these mice, as shown in Fig. 5 . Blood glucose levels of Kir6.2KO/ hIR KM TG and Kir6.2KO mice declined at 2300 h probably by incretin (as well as by acetylcholine and PACAP)-induced insulin secretion by ingestion of a mixed meal [1] . Excess fall of blood glucose levels of these two genotypes at 2400 h may be due to the absence of glucagon secretion in response to systemic hypoglycemia. The fluctuations in blood glucose levels in these two genotypes by fasting and re-feeding were larger than in WT mice.
HIR KM TG, Kir6.2KO and Kir6.2KO/hIR KM TG mice had an impaired glucose tolerance Glucose tolerance was assessed by giving an intraperitoneal injection of glucose after a 14 h fast. As shown in Fig. 3 , fasting blood glucose levels (at 0 min) were statistically lower in the Kir6.2KO/hIR KM TG and Kir6.2KO mice than in WT mice. With a glucose challenge, the Kir6.2KO and the hIR KM TG/Kir6.2KO mice had significantly higher glucose levels at 30, 60 and 120 min compared to findings in WT mice, perhaps due to the lack of glucose-induced insulin secretion in these mice (Fig. 5) . After glucose loading, the hIR KM TG mice also had significantly higher glucose levels at 20, 30, 60 and 120 min compared to findings in WT mice 
. Fasting and random-fed blood glucose levels
Fasting (open bar) and random-fed (closed bar) blood glucose concentrations were measured in male mice 12-16 weeks old. For the fast, the standard chow was removed from their cages at 0800 h. After mice had fasted as described, for 6 h (from 0800 h to 1400 h), blood samples were obtained at 1400 h from the tail vein. Random-fed blood samples were obtained at 1400 h from tail vein. Values are presented as mean ± SD for WT (wild type; control) mice (n = 13), hIR KM TG (n = 10), Kir6.2KO (n = 12) and Kir6.2KO/hIR KM TG (n = 12). Significance was determined using Student's t test. *P<0.05 vs. WT.
Fig. 3. Mixed meal tolerance test
Male mice (12-18 weeks old) were moved into new cages without standard chow at 0900 h and were fasted for 12 h (0900 h-2100 h). The mice were allowed free access to chow for one hour (2100 h-2200 h) and the standard chow was removed and their cages changed at 2200 h. Blood glucose concentrations were measured at the indicated times. Results are expressed as mean ± SD for WT mice (open circles, n = 12), hIR KM TG mice (closed circles, n = 15), Kir6.2KO mice (open squares, n = 23) and Kir6.2KO/hIR KM TG mice (solid squares, n = 6). *P<0.05, **P<0.01 vs. WT. (Fig. 4) . The glucose intolerance of the hIR KM TG mice in this test was more significant than that in our previous report [13] . Kir6.2KO/hIR KM TG mice did not show the additive glucose intolerance in ipGTT. The glucose intolerance of Kir6.2KO/hIR KM TG was comparable to findings with that of Kir6.2KO mice.
Defective insulin secretion of Kir6.2KO and Kir6.2KO/hIR KM TG mice, and prolonged insulin secretion of hIR KM TG mice during ipGTT
Since the hIR KM TG, Kir6.2KO/hIR KM TG and Kir6.2KO mice had an impaired glucose tolerance in ipGTT (Fig. 4) , we evaluated the plasma insulin concentration of these mice during ipGTT. As reported [7] , the plasma insulin levels of the Kir6.2KO mice were unchanged in response to glucose loading (Fig. 5) . Insulin response to glucose loading in Kir6.2KO/ hIR KM TG mice was comparable to that seen in Kir6.2KO mice. Both strains showed a lack of glucose-induced insulin secretion. The hIR KM TG mice had prolonged insulin secretion in response to glucose loading. In WT mice, insulin levels in response to glucose loading reached a maximum at 20 min and then returned to the basal level 60 min later. However, the plasma insulin levels of hIR KM TG mice did not return to the basal level even after 60 min. The prolonged insulin secretion is probably due to insulin resistance or abnormal insulin secretion.
Insulin tolerance test
After a 6 h fasting (0830 h-1430 h), the glucose level of hIR KM TG mice was comparable to that of WT as shown in Fig. 2 . However, the insulin (0.2 U/kg)-induced reduction of blood glucose levels during the insulin tolerance test was blunted in hIR KM TG mice compared to findings in WT mice (Fig. 6) . On the other hand, fasting blood glucose levels in Kir6.2KO mice were lower than that in WT mice as shown in Fig. 2 , and blood glucose levels in those mutant mice were lower than that in WT mice during insulin tolerance test (Fig. 6 ). In accordance with a previous report [9] , the glucose-lowering effects during the insulin tolerance test were enhanced in Kir6.2KO mice compared to findings in WT mice.
Kir6.2KO, Kir6.2KO/hIR KM TG and hIR KM TG mice showed decreases in whole-body glucose disposal in the hyperinsulinemic euglycemic clamp test
As a more critical indicator of insulin action, wholebody glucose disposal was assessed by the hyperinsulinemic euglycemic clamp test. The glucose infusion rate (GIR) of the hIR KM TG mice was slightly but significantly decreased compared to that in WT mice (Fig. 7) . This result was as expected, because both ipGTT (Fig. 4) and ITT (Fig. 6) showed insulin resistance in hIR KM TG mice. Surprisingly, Kir6.2KO mice, which are defective in glucose-induced insulin secretion (Fig. 5) , clearly exhibited a more significantly decreased whole-body glucose disposal, despite the enhanced glucose uptake by skeletal muscle and adipose tissue by insulin in vivo, compared to findings in wild-type mice as reported earlier [9] . The Kir6.2KO/ hIR KM TG mice also had a decreased whole-body glucose disposal.
Although the double mutant mice had both a lack of glucose-stimulated insulin secretion and a significant insulin resistance, the mice did not exhibit diabetes because of low blood glucose level at the fasting state (Figs. 2, 3, 4) .
Kir6.2KO mice showed increased epididymal fat weight and hyperleptinemia
To determine why the Kir6.2KO mice showed decreased whole-body glucose disposal, as shown in Fig. 7 , we determined circulating lipid and leptin concentrations. Abnormalities in lipid metabolism can modulate insulin secretion and insulin sensitivity. Body weight and epididymal fat weight of Kir6.2KO mice increased by approximately 10% and 70%, respectively (Tables 1 and 2 ). No significant difference . Glucose infusion rate in hyperinsulinemic euglycemic clamp showed insulin resistance of Kir6.2KO/hIR KM TG mice After male mice had been fasted for 14 h, they were anesthetized with pentobarbital and a catheter was inserted into the right jugular vein for insulin and glucose infusion at 0800 h. Insulin and glucose were infused simultaneously at a constant rate (15 mU·kgBW -1 · min -1 ) and at a variable rate to maintain the target plasma glucose of 110 mg/dl. The total body glucose uptake represents the mean glucose infusion rate (GIR) during the last 20 min. Results are expressed as mean ± SD for WT mice (open bar, n = 7), hIR KM TG mice (stippled bar, n = 6), Kir6.2KO mice (hatched bar, n = 10), Kir6.2KO/hIR KM TG mice (closed bar, n = 5). *P<0.05, **P<0.01 vs. WT.
was found in the free fatty acid and total cholesterol levels in the fasting state. Triglyceride levels decreased by 35% and leptin concentrations were increased by 10 fold in the Kir6.2KO mice (Table 2) . Interestingly, all parameters on Kir6.2KO/hIR KM TG mice were comparable to findings in wild type mice. Particularly, the normalization of the leptin levels in Kir6.2KO/ hIR KM TG mice is probably caused by the normalization of body weight and fat weight. We also measured the feed intake of these mice and found that the feeding rates (feeding amount per body weight) were comparable ( Table 1 ). Only Kir6.2KO mice exhibited significantly, heavier body weight compared to other mice, hence the actual feed intake of these mice was greater than that of the other groups. The decreased whole-body glucose disposal of Kir6.2KO mice in the hyperinsulinemic euglycemic clamp test is partly due to increased body weight and fat mass by virtue of increased food intake.
Insulin-stimulated activation of AKT kinase in livers of the four genotypes
We earlier reported that the insulin action in the liver of hIR KM TG mice was not inhibited, because the exogenous dominant negative mutant insulin receptor (IR) in liver was about one tenth that of the endogenous mouse IR [10, 13] . To rule out the defect of insulin signaling in the liver of the four genotypes, we examined the insulin-stimulated AKT activities in liver. AKT is a key signaling molecule for insulin action in the liver. AKT has been shown to phosphorylate and inhibit glycogen synthase kinase 3, and subsequently promote glycogen synthesis in response to insulin [19] . Insulin-stimulated AKT kinase activation in the liver from hIR KM TG, Kir6.2KO and Kir6.2KO/ hIR KM TG was not impaired compared to findings from WT mice. Insulin-stimulated PI-3 kinase activities were not different in the livers of these mice (data not shown), indicating that insulin signaling was not impaired in the livers of these mice. Body weight (g) of male mice was measured and meal intake (g meal intake/g body weight/day) was estimated at 8-12 weeks old. Data represent mean ± SD. *P<0.05, **P<0.01 vs. wild type. Lipid metabolism was evaluated in three genotypes of male mice (12-17 weeks old). Blood samples were obtained from the tail vein after (18:00-8:00) fasting by completely removing the chow. Serum levels of triglyceride, total cholesterol and free fatty acid were determined by conventional enzymatic methods (Wako, Osaka, Japan). Plasma leptin level was measured by ELISA kit.
Epididymal fat weight was measured on the three genotypes (16-19 weeks old). Data represent mean ± SD for n = 5~7 mice in each group. *P<0.05, **P<0.01 vs. WT.
Discussion
Kir6.2KO mice unexpectedly exhibited clear decrease in whole-body glucose disposal compared with findings in WT mice in the hyperinsulinemic euglycemic clamp test (Fig. 7) . This effect may not be due to insulin resistance of skeletal muscle or adipose tissue of Kir6.2KO mice, because Miki et al. earlier found that insulin-stimulated glucose uptake of these tissues in Kir6.2KO mice was enhanced in vivo [9] . These results indicate that Kir6.2KO mice have an impaired glucose metabolism leading to decreased whole-body glucose disposal, in addition to defects of glucoseinduced insulin secretion [7] and of glucagon secretion in response to systemic hypoglycemia [8] .
However, we cannot rule out the possibility that different environmental conditions may cause phenotypic differences in Kir6.2KO mice. The Kir6.2KO mice kept at the University of Tokushima for the present experiments showed a slight obesity and hyperleptinemia (Tables 1 and 2 ). The obesity was not evident under normal conditions and with a normal diet when Kir6.2KO mice were kept at Chiba University [7] . In the present study, Kir6.2KO mice in which weight and serum leptin levels were higher than in WT mice (Tables 1 and 2) , might have a decreased whole-body glucose disposal partly due to insulin resistance in skeletal muscle and adipose tissue.
As shown in Tables 1 and 2 , Kir6.2KO mice showed increased fat mass, body weight and hyperleptinemia. We presumed that the fact that Kir6.2 KO mice had a severe defect in glucagon secretion in response to systemic hypoglycemia [8] and therefore had to eat chow continuously to prevent severe hypoglycemia, was the reason why they subsequently became obese. Their 6, 12, and 14 hr fast glucose levels were lower than WT mice as shown in Figs. 2, 3 and 4 , respectively. This behavior increased their body weight and fat mass, and subsequently resulted in increased plasma leptin levels. In fact, although the feeding rates (feeding amount per body weight) were comparable among the 4 groups, the absolute amount of food intake by Kir6.2KO was significantly greater than that of the other groups. By contrast, Kir6.2KO/hIR KM TG mice did not show increased fat mass, body weight, food intake and hyperleptinemia (Tables 1 and 2 ). Because these mice have the insulin resistant phenotype of hIR KM TG mice as shown in Figs. 2 and 7 , they could avoid severe hypoglycemia after 6 h fast (Fig. 2) . Thus, we concluded that the hyperleptinemia observed in Kir6.2KO mice was secondary to the obesity, since the double mutant mice (i.e., Kir6.2KO/hIR KM TG) mice exhibited normal body weight and normal food intake as well as normal leptin level in spite of the genetic disruption of Kir6.2 gene.
We detected the insulin resistance of hIR KM TG mice using ipGTT (Fig. 4) and ITT (Fig. 6 ) as well as in the hyperinsulinemic euglycemic clamp test (Fig. 7) where it was detected more clearly than earlier reported [10] . We found that the hIR KM TG mice had a prolonged insulin secretion during ipGTT (Fig. 5) . The insulin response to glucose loading in hIR KM TG mice was slightly impaired compared to findings in control mice, as reported [12] . We considered that the prolonged insulin secretion of hIR KM TG mice might be due to the insulin resistance of the mice, although the expression of mutant human insulin receptor in b cells of hIR KM TG mice was not significantly detected using human specific monoclonal antibody 5D9 (data not shown).
The defect in glucagon secretion by the Kir6.2KO/ hIR KM TG mice may not be the major cause of their failure to develop diabetes, since Kir6.2KO mice, when obese and 55-60 weeks old, had diabetes [1] . Thus if Kir6.2KO mice with a defect in glucoseinduced insulin secretion were to acquire insulin resistance, they could have diabetes.
We earlier suggested that diabetes hardly develops in mice in the absence of a liver defect in insulin action [13] . We did not detect the impaired insulin signaling and actions in livers of Kir6.2KO and hIR KM TG mice (Fig. 8) . Kir6.2KO/hIR KM TG mice lacked fasting hyperglycemia by normal insulin action in the liver. However, Terauchi et al. reported that the double knockout mice with disruption of insulin receptor substrate 1 and b cell glucokinase genes showed overt diabetes [20] . When the defects of insulin secretion and insulin action are serious, these double defects could lead to diabetes without the defect in insulin action in the liver. Impaired insulin action in the liver of Kir6.2KO/hIR KM TG mice might lead to the development of overt diabetes.
